Treasury Chief Reeves Aims for Targeted Measures on Household Expenses in Upcoming Budget
Treasury head Rachel Reeves has stated she is planning "specific measures to address cost of living pressures" in the forthcoming Budget.
In comments to the BBC, she emphasized that reducing price rises is a joint duty of both the administration and the Bank of England.
The United Kingdom's price growth is expected to be the highest among the G7 industrialized countries this year and the following year.
Potential Utility Bill Interventions
It is understood the government could intervene to lower utility costs, for instance by slashing the present 5% rate of VAT applied on energy.
A further option is to reduce some of the policy costs presently included in household expenses.
Budgetary Constraints and Expert Expectations
The government will receive the next assessment from the official forecaster, the Office for Budget Responsibility, on the start of the week, which will clarify how much room there is for such actions.
The view from the majority of analysts is that Reeves will have to introduce tax increases or expenditure reductions in order to meet her declared debt limits.
Earlier on Thursday, calculations showed there was a £22bn gap for the Treasury chief to address, which is at the lower end of projections.
"It is a collective responsibility between the Bank of England and the administration to bear down further on some of the causes of inflation," Reeves told the BBC in Washington, at the yearly gatherings of the International Monetary Fund and World Bank.
Revenue Commitments and Global Issues
While a great deal of the focus has been on likely tax increases, the chancellor said the latest information from the fiscal watchdog had not changed her commitment to manifesto promises not to increase tax levels on income tax, sales tax or National Insurance.
She attributed an "uncertain global environment" with growing geopolitical and trade concerns for the fiscal tax moves, probably to be targeted on those "with the broadest shoulders."
Global Economic Disputes
Addressing apprehensions about the UK's commercial links with China she said: "Our security interests always are paramount."
Recent statement by China to strengthen export controls on rare earths and other resources that are key for high-technology manufacturing led US President the US President to suggest an further 100% tariff on goods from the Asian country, raising the risk of an full-scale commercial conflict between the two economic giants.
The American finance chief described the Chinese action "commercial pressure" and "a international production power grab."
Inquired about considering the US offer to participate in its dispute with the Asian nation, the Chancellor said she was "extremely troubled" by China's measures and encouraged the Beijing authorities "to avoid restrictions and limit trade."
She said the action was "harmful for the world economy and generates additional headwinds."
"It is my opinion there are areas where we must challenge China, but there are also important opportunities to trade with China's economy, including banking sector and other sectors of the economic system. We've got to get that balance appropriate."
The chancellor also stated she was cooperating with G7 counterparts "regarding our own essential resources strategy, so that we are reduced dependence."
Health Service Drug Pricing and Investment
The Chancellor also recognized that the cost the NHS spends on drugs could increase as a consequence of ongoing negotiations with the US government and its drugs companies, in exchange for lower tariffs and capital.
Some of the biggest global drug companies have said recently that they are either halting or canceling projects in the United Kingdom, with some attributing the modest returns they are getting.
Recently, the Science Minister said the cost the NHS spends on medicines would must increase to halt businesses and drug research funding leaving the United Kingdom.
Reeves told media: "We have seen because of the payment system, that medical research, recent pharmaceuticals have not been available in the United Kingdom in the manner that they are in other EU nations."
"We want to make sure that individuals getting treatment from the NHS are can receive the best essential medicines in the world. And so we are examining all of that, and... seeking to secure additional investment into the UK."